维普中文期刊产品整合服务
128篇 您的检索式:作者名="POPAT R"
    题名 作者 年代 出处 被引量
1Chondroitinase ABC promotes functional recovery after spinal cord injury 显示文摘Bradbury E J Moon L D F Popat R J 2002Nature2002,416,:1
2Use of bortezomib as induction therapy prior to stem cell transplantation in frontline treatment of multiple myeloma:impact on stem cell harvesting and engraftment显示文摘Oakervee H Popat R Cavenagh JD 0,,:1
3Difficuh Airway Society Guidelines for the management of tracheal extubation 显示文摘Popat M Mitchell V Dravid R 2012Anaes- thesia2012,67,3:1
4Systematic review of microsatel-lite instability and colorectal cancer prognosis显示文摘Popat S Hubner R Houlston RS 2005J Clin Oncol2005,23,3:1
5PAD combination therapy(ps-341/bortezomib, doxorubicin and dexamethasone)for previously untreated patients with multiple myeloma显示文摘OAKERVEE HE POPAT R CURRY N 2005Br J Haematol2005,129,6:1
6Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type A and correlations with lower urinary tract symptoms and urodynamic changes显示文摘Kalsi V Apostolidis A Popat R 0,,03:1
7Chondrotiti-nase ABC promotes functional recovery after spinal cord injury显示文摘 MOON L D POPAT R J 2002Nature2002,416,6881:1
8Chondroitinase ABC promotes functional recovery after spinal cord injury 显示文摘Bradbury E J Moon LD Popat R J 2002Nature2002,416,:1
9Systematic review of mi- erosatellite instability and colorectal cancer prognosis显示文摘Popat S Hubner R Houlston RS 2005J Clin Oncol2005,23,3:1
10Difficult airway society guidelines for the management of tracheal extubation显示文摘COOPER R M O'SULLIVAN E POPAT M 2013Anaesthesia2013,68,2:1
11A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the fast intradetrusor injection of botulinum-A toxin显示文摘Popat R Apostolidis A Kalsi V 0,,03:1
12Bortezomib (Velcade), thalidomide, dexamethasone and panobinostat ( VTD-P ) is a safe, well tolerated and efficacious regimen for patients with relapsed multiple myeloma:preliminary results of the Muk-Six trial 显示文摘Popat R MBBS RP Brown SR 2015Blood2015,126,23:1
13PAD combination therapy(PS-341/bortezomib, doxorubicin and dexamethasone) for previouslyuntreated patients with multiple myeloma 显示文摘Oakervee HE Popat R Curry N 2005Br J Haematol2005,129,6:1
14PAD combination therapy ( PS-341/bortezomib, doxorubicin and dexamethasone ) for previously untreated patients with multiple myeloma 显示文摘Oakervee H Popat R Curry N 2005Br J Haematol2005,129,6:1
15PAD combination therapy (PS-341/ bortezomib,doxorubicin and dexamethasone)for previously untreated patients with multiple myeloma显示文摘Oakervee HE Popat R Curry N 2005Br J Haematol2005,129,6:1
16High dose chemotherapy for relapsed and refractory diffuse large B cell lymphoma: mediastinal loeafizafion predicts for a favorable out-come显示文摘Popat U Przepiork D Champlin R 1998J Clin Oncol1998,16,1:1
17PAD combination therapy (PS-341/bortezomib,doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma显示文摘Oakervee HE Popat R Curry N 2005Br J Haematol2005,129,6:1
18Bortezomib,doxorubicin and dexamethasone (PAD) front-line treatment of multiple myeloma:updated results after long-term follow-up显示文摘Popat R Oakervee HE Hallam S 2008Br J Haematol2008,141,4:1
19Bone tissue engineering: A review in bone biomimeties and drug delivery strategies 显示文摘Proter J R Ruckh T T Popat K C 2009Biotechnol Prog2009,25,6:1
20Adenoid cystic carcinomaof the paranasal sinuses or nasal cavity:a 40-year review of 35case显示文摘WISEMAN S M POPAT S R RIGUAL N R 2002Ear Nose Throat J2002,81,:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费